CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 212 enrolled
Drug / intervention
Angiodynamics BioFlo Midline Catheter +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03725293
NCT03725293N/ACompleted

Randomized Comparative Evaluation of Midline Catheters for Thrombophlebitis

Corewell Health East·interventional·Posted Oct 31, 2018·Updated Jan 14, 2022

In Brief

A clinical study evaluating Angiodynamics BioFlo Midline Catheter and Teleflex Arrowg+ard Blue Advanced Midline Catheter for Catheter Infection and 2 related conditions. Completed, enrolled 212 participants across 1 site.

Detailed Summary

Peripherally inserted central catheters (PICCs) are central catheters that are placed via peripheral vein under ultrasound guidance and may be used for patients with difficult venous access for long-term central or peripheral infusion therapies as well as central venous pressure monitoring in a critical care setting. Although PICCs provide a great option for some patients, these catheters have known complications including catheter-related bloodstream infection, catheter-related venous thrombosis or clotting, malfunction, and high cost. Midline catheters represent a potentially attractive alternative to PICCs for peripheral infusions. As midlines have increased in popularity and new midlines have been introduced into the market, it is necessary to better understand complication profiles of various midline catheters, as it is likely that all catheters are not created equal. Specifically, the incidence of symptomatic catheter-related thrombosis is of interest. Some midline catheters are coated to provide protection against catheter-related venous thrombosis and/or catheter-related bloodstream infection. The theoretical benefit(s) of these catheters need further validation in human subjects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsTeleflex

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 31, 2018
Enrollment StartJan 14, 2019
Primary CompletionNov 26, 2020
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 7.7 years ago

Interventions

Angiodynamics BioFlo Midline Catheterdevice

Placement of Angiodynamics BioFlo Midline Catheter.

Teleflex Arrowg+ard Blue Advanced Midline Catheterdevice

Placement of Teleflex Arrowg+ard Blue Advanced Midline Catheter.